Phathom Pharmaceuticals (PHAT) Current Deferred Revenue (2023 - 2026)
Phathom Pharmaceuticals (PHAT) recorded Current Deferred Revenue of $37.28 million in Q2 2026, up 73.2% from $21.53 million a year earlier and up 12.9% from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Current Deferred Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, Phathom Pharmaceuticals reported Current Deferred Revenue of $27.25 million, up 37.8% from FY2024.
- Across earlier years, Current Deferred Revenue came in at $19.78 million in FY2024 (+178.1%) and $7.11 million in FY2023.
- The Q2 2026 figure is the highest quarterly Current Deferred Revenue in data going back to Q2 2023.
- On a year-over-year basis, Current Deferred Revenue has increased for eight consecutive quarters, with growth averaging 158.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Current Deferred Revenue ranged from 4.8% (Q1 2025) to 744.6% (Q3 2024).
- Per Business Quant, the preceding three quarters came in at $33.02 million (Q1 2026), $27.25 million (Q4 2025) and $24.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Phathom Pharmaceuticals | 589.32 Mn | -50.64 Mn | 59.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.28 Mn |
| Mar 31, 2026 | 33.02 Mn |
| Dec 31, 2025 | 27.25 Mn |
| Sep 30, 2025 | 24.34 Mn |
| Jun 30, 2025 | 21.53 Mn |
| Mar 31, 2025 | 17.27 Mn |
| Dec 31, 2024 | 19.78 Mn |
| Sep 30, 2024 | 20.19 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Mar 31, 2024 | 16.48 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 276,000.00 |
API Access
Phathom Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();